Elisabeth R. Evans, MSN, FNP

Knowledgeable Sr. Medical Science Liaison with 5+ years experience translating complex scientific data into actionable insights for professionals. A respected Nurse Practitioner with a strong background in fostering communication and building relationships. Adept at driving organizational success through effective team collaboration and dynamic problem-solving. Regarded for providing fair balanced, objective, scientific information and education to HCPs in various therapeutic areas. Recognized for adaptability and keen focus on achieving objectives.

• 2011 - 2019 UCB Wellness Panel National Speakers Bureau and Advisory Board Member
• 2012 - 2018 Abbvie National Speakers Bureau and Advisory Board Member
• 2014 - 2019 Takada National Speakers Bureau and Advisory Board Member
• 2015 - 2019 IBDSF Medical Advisory Board Member
• 2016 - 2019 Janssen National Speakers Bureau and Advisory Board Member
• 2016 - 2022 Gastroenterology and Hepatology Advanced Practice Provider (GHAPP) Executive Council / Board of Directors
• 2017 - 2018 Sherman Foundation Selection Committee for Sherman Prize for Excellence in Crohn's and Colitis
• 2018 - 2019 Pfizer National Speakers Bureau
• 2018 - 2019 Prometheus National Speakers Bureau
• 2018 - 2019 AGA IBD Care Pathway Committee Member
• 2020 - 2023 AGA Clinical Advisory Network
• 2023 - present GHAPP Trustee Emeritus

• Rutkowski E , Lozano DD, Hansbrough JF: Comparison of Collagenase and a Urea-Papain Preparation as Debriding Agents for Full-thickness Burns in Mice. Submitted to Journal of Burn and Rehabilitation 10/2002.
• Robinson L, Camblin J, Evans, E : The Role of the Home Health Nurse in Acquired Immune Deficiency Syndrome Related Cryptococcal Meningitis. Submitted to Journal of the Association of Nurses in AIDS Care 6/2006.
• Pola S, Patel D, Ramamoorthy S, McLemore E, Fahmy M, Rivera-Nieves J, Chang JT, Evans E , Docherty M, Talamini M, Sandborn WJ: Strategies for the Care of Adults Hospitalized for Active Ulcerative Colitis. Clin Gastroenterol Hepatol. 2012 Dec;10(12):1315-1325.e4. DOI: 10.1016/j.cgh.2012.07.006. Epub 2012 Jul 24. Review.
• Pola S, Fahmy M, Evans E , Tipps A, Sandborn WJ: Successful Use of Infliximab in the Treatment of Corticosteroid Dependent Collagenous Colitis. Am J Gastroenterol. 2013 May;108(5):857-8. DOI: 10.1038/ajg.2013.43.
• Bouguen G, Evans E , Sandborn WJ: Azathioprine-induced Neuro-psychiatric Disorders. Journal of Crohn's & Colitis. 2014 Feb;8(2):180. DOI: 10.1016/j.crohns.2013.09.014. Epub 2013 Oct 5.
• Bouguen G, Levesque BG, Pola S, Evans E , Sandborn WJ: Feasibility of Endoscopic Assessment and Treating to Target to Achieve Mucosal Healing in Ulcerative Colitis. Inflamm Bowel Dis. 2014 Feb;20(2):231-9. DOI:10.1097/01.MIB.0000437985.00190.aa.
• Bouguen G, Levesque BG, Pola S, Evans E , Sandborn WJ: Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients with Crohn's Disease. Clin Gastroenterol Hepatol. 2014 Jun;12(6):978-85. DOI: 10.1016/j.cgh.2013.11.005. Epub 2013 Nov 15.
• Boland BS, Rivera-Nieves J, Jain A, Kirkland R, Liu X, Kondragunta V, Evans E, Levesque BG, Ernst PB, Chang JT, Singh S, Sandborn W: Soluble MAdCAM-1: A Potential Biomarker for Response to Vedolizumab. Gastroenterology. 2015 April: 148(4): S106-S107. DOI: https://doi.org/10.1016/S0016-5085(15)30367-X
• Meserve JD, Dulai P, Park S, Evans E , Singh S, Sandborn WJ, Boland BS: Vedolizumab does not Increase the Risk of Enteric Infections as Compared to Infliximab: A Retrospective Cohort Study. Gastroenterology. 2017 April; 152 (5): S109-S110. DOI: http://dx.doi.org/10.1016/S0016-5085(17)30706-0
• Kurnool S, Nguyen NH, Proudfoot J, Dulai PS, Boland BS, Vande Casteele N, Evans E , Grunvald EL, Zarrinpar A, Sandborn WJ, Singh S: Higher Body Mass Index is Associated with Increased Risk of Treatment Failure and Surgery in Biologic-Treated Patients with Ulcerative Colitis. Gastroenterology. 2018 Jan;154(1):S102. DOI: https://doi.org/10.1053/j.gastro.2017.11.241
• Park S, Evans E, Sandborn WJ, Boland B: Ustekinumab IV 6mg/kg Loading Dose Re-Induction Improves Clinical and Endoscopic Response in Crohn's Disease: A Case Series. Am J Gastroenterology. 2018 April;113(4):627-629. DOI: 10.1038/ajg.2018.22
• Battat R, Dulai PS, Vande Casteele N, Evans E, Hester KD, Webster E, Jain A, Proudfoot JA, Mariralles A, Neill J, Singh S, Chang JT, Rivera-Nieves J, Sandborn WJ, Boland BS: Biomarkers are Associated with Clinical and Endoscopic Outcomes with Vedolizumab Treatment in Ulcerative Colitis. Inflammatory Bowel Disease. 2019 Jan 10; 25(2):410-420. PMID: 30295781
• Kinnucan J, Binion D, Cross R, Evans E , Harlen K, Matarese L, Mullins A, O'Neal B, Reiss M, Scott FI, Weaver A, Rosenberg J: Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology.2019 DOI: https://doi.org/10.1053/j.gastro.2019.03.064
• Drescher H, LIssoos T, Hajisafari E, Evans ER : Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers. The Journal for Nurse Practitioners. 2019 October; 15(9):676-681. https://doi.org/10.1016/j.nurpra.2019.07.015

• Rutkowski ER , Lozano DD, and Hansbrough JF: A Comparison of Full-Thickness Burns in Mice Treated with Collagenase* versus Papain-Urea Ointment.** Presented at the Fourteenth Annual Symposium on Advanced Wound Care & Medical Research Forum on Wound Repair in Las Vegas, Nevada, April 2001.
• Lozano DD, Rutkowski ER , Noordenbos JM, Dore' CM, Hansbrough JF: The use of Fibroblast Derived Temporary Skin Substitutes for Prolonged Wound Coverage. Presented at the Fourteenth Annual Symposium on Advanced Wound Care & Medical Research Forum on Wound Repair in Las Vegas Nevada, April 2001.
• Boland BS, Hester H, Salbato J, Chon K, Christie R, Evans E, Renshaw M, Mimms L, Jain A, Sandborn WJ: Association of Ustekinumab Concentrations using Anser UST Mobility Shift Assay and Clinical Response in Crohn's Disease. Presented at Advances in Inflammatory Bowel Disease in Orlando Florida, Nov 2017.
• Park S, Evans E , Sandborn WJ, Boland B: Ustekinumab IV 6mg/kg loading dose re-induction improves clinical and endoscopic response in Crohn's disease: a case series. Presented at Advances in Inflammatory Bowel Disease in Orlando Florida, Nov 2017
• Evans ER, Scherl E, Powers Yopp L, Kerekes A, Joseph M, Simone LC, Greene L, Sapir T: Patient Education on Inflammatory Bowel Disease (IBD) Guided by Assessments of Patient and Provider Team Perceptions. Presented at American College of Gastroenterology in Philadelphia, PA Oct 2018.
• Battat R, Boland B, Singh S, Collins A, Evans ER , Valasek M, Jain A, Sandborn WJ, Dulai P. Diagnostic Accuracy of the Serum-Based Mucosal Health Index Assay in Crohn's Disease and Comparative Accuracy in Crohn's Disease and Comparative Accuracy to Fecal Calprotectin in Routine Practice. Presented at CCF IBD Congress for 2nd Annual Meeting, Las Vegas 2019.
• Evans ER. Outcomes of the Inaugural Gastroenterology and Hepatology Advanced Practitioner Provider National Conference, an Unparalleled Opportunity for Tailored Education, Professional Development and Networking. Presented at Digestive Disease Week Annual Meeting, San Diego 2019.

• Rutkowski ER and Hansbrough JH: An Evaluation of Sensory Responses and Epithelialization in Partial Thickness Burns in Rats. Presented at the John Boswick, MD Annual Meeting of the Burn & Wound Care Symposium in Maui, Hawaii, February 2001.
• Rutkowski ER and Hansbrough JF: A Comparison Study on the Effects of Collagenase on Partial Thickness Wounds in Rats. Presented at the John Boswick, MD Annual Meeting of the Burn & Wound Care Symposium in Maui, Hawaii, February 2001.
• Lozano DD, Rutkowski ER , Noordenbos JM, Dore' CM, Hansbrough JF: The Use of Fibroblast Derived Temporary Skin Substitutes for Prolonged Wound Coverage. Presented at the American Burn Association 33rd Annual Meeting in Boston, April 2001.
• Lozano DD, Rutkowski ER , Rennekampff H, Hansbrough, JF: The Effect of a Fibroblast Derived Skin Substitute on Keratinocyte Proliferation. Presented at the John Boswick, MD Annual Meeting of the Burn & Wound Care Symposium in Maui, Hawaii, February 2002.
• Rutkowski ER and Lozano DD: Debridement of Burns in Mice Treated with Different Formulations of Collagenase SANTYL® Ointment. Presented at the American Burn Association 34th Annual Meeting in Chicago, April 2002.
• Evans ER : Inflammatory Bowel Disease Nursing. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA, Sept 7, 2013
• Evans ER: FAQ's for RN's in Inflammatory Bowel Disease. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA, Sept 6, 2014.
• Evans ER: Updates for RN's in Inflammatory Bowel Disease. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA Sept 10, 2015
• Cross R and Evans ER : Optimizing IBD Quality and Treatment Outcomes: Competencies for Nurse Practitioners, Physician Assistants, and Specialty Nurses. Presented at American College of Gastroenterology Annual Meeting in Honolulu, HI Oct 18, 2015.
• Evans ER, Kissous-Hunt M and Velayos F: What 1,600 IBD Chart Audits Tell us About Quality of Care & How we Can Improve. Presented at Advances in Inflammatory Bowel Disease in Orlando, FL Dec 11, 2015.
• Evans, ER and Collins, A: Clinical Case Studies in IBD. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA Sept 10, 2016
• Boland, BS and Evans, ER: Long Term Success in IBD. Developing Strategies to Individualized Therapy. SGNA Regional Conference in Napa, CA March 18, 2017
• Boland, BS and Evans, ER: Long Term Success in IBD. Developing Strategies to Individualized Therapy. SGNA Regional Conference in Orange County, CA March 11, 2017
• Evans, E: IBD Treatment Options. Presented at Crohn's and Colitis Foundation La Jolla Patient Education Conference in La Jolla CA April 25, 2017
• Evans, ER and Collins, A: IBD Clinical Pearls – Learning Through Case Studies. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA Sept 9, 2017
• Evans, ER and Reiss, M: IBDSF Core Competencies for Advanced Practice Providers. Addressing Core IBD Competencies in Medical Care, Health Management and Psychosocial Care. Los Angeles, CA July 14 – July 15, 2018
• Evans, ER : Prior Authorizations – Tips for Success. Presented at the New Advances in Inflammatory Bowel Disease Conference in San Diego, CA Sept 9, 2018
• Evans, ER : Management and Healthcare Maintenance of a Patient with Moderate to Severe UC managed with Tofacitinib. Presented at GHAPP National Conference in Las Vegas, NV Sept 9, 2018.
• Evans, ER: Effective Communication = Improved Outcomes. Presented at 2019 Crohn's and Colitis Congress in Las Vegas, NV Feb 7, 2019
• Evans, ER: A Deep Dive- Understanding Ulcerative Colitis for the Advanced Practice Provider. Presented at GHAPP 2019 National Conference. Las Vegas, NV Sept 6, 2019.
• Evans, ER : Updates in Colorectal Cancer Screening 2020. Presented at GHAPP 2020 National Conference. Las Vegas, NV Nov 20, 2020.
• Evans, ER: Roadmap to De-esculation and Stopping IBD Therapy: Presenting Data from TAXIT and STORI Clinical Trials. Presented at GHAPP 2021 National Conference. Las Vegas, NV Sept 11, 2021.
• Evans, ER : IBD Boot CAMP 101 4 hour CME course. Presented at GHAPP 2022 National Conference. Nashville, TN. Sept 29, 2022.
• Evans, ER : Hitting the Bull's Eye in Treat to Target for IBD. Presented at GHAPP 2022 National Conference. Nashville, TN. Oct 1, 2022.

WebMD Professional Resources 2018

Extinguishing Inflammation: Evolving Challenges in IBD

• Hallmarks of IBD https://www.medscape.com/mtv/inflammatory-bowel-disease-s01/e01?src=1_EMA_U_N&uac=83983SN
• An Evolving Target https://www.medscape.com/mtv/inflammatory-bowel-disease-s01/e02?src=1_EMA_U_N&uac=83983SN
• Treat to Target https://www.medscape.com/mtv/inflammatory-bowel-disease-s01/e03?src=1_EMA_U_N&uac=83983SN

PRIME CME Monograph 2014 – 2016

Program Affiliation History

• (11/09/16) A Practical Guide for Collaborative Partnerships Among Patients and Care Providers in IBD Health
• (10/16/15) Building Competencies in Inflammatory Bowel Disease: On-Demand e-Library for the Interprofessional Team
• (5/02/14) Optimizing IBD Quality of Care and Treatment Outcomes for Team-Based Competencies
• (5/02/14) What 1600 IBD Chart Audits Tell Us About Quality of Care and How We Can Improve
• (5/01/14) Expanding Roles of Nurse Practitioners, Physician Assistants, and Specialty Nurses in Quality IBD Care
• (5/01/14) Advancing Clinical Skills Among the Interprofessional Team to Optimize IBD Treatment Outcomes

• 2015 UC San Diego Health System Advanced Practice – Exemplary Professional Practice Award
• 2017 Crohn's and Colitis Foundation –Top 50 IBD Providers in 50 years
• 2018 Crohn's and Colitis Foundation – Honoree Race for a Cure Benefit
• 2020 Medical Science Liaison Society – MSL “Rookie of the Year” nominee